Recurrence of status epilepticus: Prognostic role and outcome predictors

Epilepsia

Volumn 56, Issue 3, 2015, Pages 473-478

  Tsetsou, Spyridoula ^a   Novy, Jan ^a   Rossetti, Andrea O ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Etiology; Female; Gender; Mortality; Prognosis; Risk

Indexed keywords

ADULT; ARTICLE; DEMOGRAPHY; EPILEPTIC STATE; FATALITY; FEMALE; GENDER; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; SCORING SYSTEM; STATUS EPILEPTICUS SEVERITY SCORE; SURVIVAL; AGED; COHORT ANALYSIS; ELECTROENCEPHALOGRAPHY; MIDDLE AGED; OBSERVATION; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; RISK FACTOR; STATUS EPILEPTICUS; VERY ELDERLY;

ANTICONVULSIVE AGENT;

ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; COHORT STUDIES; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSERVATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RISK FACTORS; STATUS EPILEPTICUS;

EID: 84924984578     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12903     Document Type: Article

References (29)

1. Lowenstein DH, Alldredge BK,. Status epilepticus. N Engl J Med 1998; 338: 970-976.
2. DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996; 46: 1029-1035.
3. Coeytaux A, Jallon P, Galobardes B, et al. Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology 2000; 55: 693-697.
4. Logroscino G, Hesdorffer DC, Cascino G, et al. Short-term mortality after a first episode of status epilepticus. Epilepsia 1997; 38: 1344-1349.
5. Towne AR, Pellock JM, Ko D, et al. Determinants of mortality in status epilepticus. Epilepsia 1994; 35: 27-34.
6. Rossetti AO, Hurwitz S, Logroscino G, et al. Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry 2006; 77: 611-615.
7. Sutter R, Kaplan PW, Ruegg S,. Outcome predictors for status epilepticus-what really counts. Nat Rev Neurol 2013; 9: 525-534.
8. Hesdorffer DC, Logroscino G, Cascino G, et al. Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus. Ann Neurol 1998; 44: 908-912.
9. Holtkamp M, Othman J, Buchheim K, et al. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry 2005; 76: 534-539.
10. Hesdorffer DC, Logroscino G, Cascino GD, et al. Recurrence of afebrile status epilepticus in a population-based study in Rochester, Minnesota. Neurology 2007; 69: 73-78.
11. Knake S, Rosenow F, Vescovi M, et al. Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia 2001; 42: 714-718.
12. Novy J, Logroscino G, Rossetti AO,. Refractory status epilepticus: a prospective observational study. Epilepsia 2010; 51: 251-256.
13. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010; 51: 676-685.
14. Lowenstein DH, Bleck T, Macdonald RL,. It's time to revise the definition of status epilepticus. Epilepsia 1999; 40: 120-122.
15. Rossetti AO, Logroscino G, Milligan TA, et al. Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy. J Neurol 2008; 255: 1561-1566.
16. Sutter R, Kaplan PW, Ruegg S,. Independent external validation of the status epilepticus severity score. Crit Care Med 2013; 41: e475-e479.
17. Rossetti AO, Logroscino G, Bromfield EB,. A clinical score for prognosis of status epilepticus in adults. Neurology 2006; 66: 1736-1738.
18. Tsai MH, Chuang YC, Chang HW, et al. Factors predictive of outcome in patients with de novo status epilepticus. QJM 2009; 102: 57-62.
19. Gross RA, Johnston KC,. Levels of evidence: taking neurology to the next level. Neurology 2009; 72: 8-10.
20. Alvarez V, Januel JM, Burnand B, et al. Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam. Epilepsia 2011; 52: 1292-1296.
21. Dham BS, Hunter K, Rincon F,. The epidemiology of status epilepticus in the United States. Neurocrit Care 2014; 20: 476-483.
22. Mosca L, Barrett-Connor E, Wenger NK,. Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation 2011; 124: 2145-2154.
23. Knake S, Rochon J, Fleischer S, et al. Status epilepticus after stroke is associated with increased long-term case fatality. Epilepsia 2006; 47: 2020-2026.
24. Alvarez V, Januel J-M, Burnand B, et al. Role of comorbidities in outcome prediction after status epilepticus. Epilepsia 2012; 53: e89-e92.
25. Cascino GD, Hesdorffer D, Logroscino G, et al. Morbidity of nonfebrile status epilepticus in Rochester, Minnesota, 1965-1984. Epilepsia 1998; 39: 829-832.
26. Cherian A, Thomas SV,. Status epilepticus. Ann Indian Acad Neurol 2009; 12: 140-153.
27. Rossetti AO, Novy J, Ruffieux C, et al. Management and prognosis of status epilepticus according to hospital setting: a prospective study. Swiss Med Wkly 2009; 139: 719-723.
28. Rossetti AO, Alvarez V, Januel JM, et al. Treatment deviating from guidelines does not influence status epilepticus prognosis. J Neurol 2013; 260: 421-428.
29. Rossetti AO, Lowenstein DH,. Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol 2011; 10: 922-930.